title: Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors' reply.
authors.affiliation: Cedars Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Gerich
authors.forename: J
authors.initials: J
authors.lastname: Yoon
authors.forename: E
authors.initials: E
authors.lastname: Vasiliauskas
mesh_terms: D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide